Litcius/Paper detail

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia

Charles Tacquard, Alexandre Mansour, Alexandre Godon, Julien Godet, Julien Poissy, Delphine Garrigue, Éric Kipnis, Sophie Hamada, Paul‐Michel Mertès, Annick Steib, Mathilde Ulliel‐Roche, Bélaïd Bouhemad, Maxime Nguyen, Florian Reizine, Isabelle Gouin‐Thibault, Marie-Charlotte Besse, Nived Collercandy, Stefan Mankikian, Jerrold H. Levy, Yves Gruel, Pierre Albaladejo, Sophie Susen, Anne Godier, Pierre Albaladejo, Normand Blais, F Bonhomme, Annie Borel‐Derlon, Avi Cohen, J.-P. Collet, Emmanuel de Maistre, Pierre Fontana, D. Garrigue Huet, Anne Godiér, Yves Gruel, A. Godon, Brigitte Ickx, Silvy Laporte, Dominique Lasne, Juan V. Llau, Grégoire Le Gal, Thomas Lecompte, Sarah Lessire, Jerrold H. Levy, Dan Longrois, Samia Madi‐Jebara, Alexandre Mansour, Mikaël Mazighi, Patrick Mismetti, Pierre‐Emmanuel Morange, Serge Motte, François Mullier, N. Nathan, Philippe Nguyên, Gilles Pernod, Nadia Rosencher, Stéphanie Roullet, P.-M. Roy, S. Schlumberger, Piérre Siè, A. Steib, Sophie Susen, Charles Tacquard, Sophie Testa, André Vincentelli, Paul Zufferey

2021CHEST Journal64 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)PneumoniaCritically ill2019-20 coronavirus outbreakIntensive care medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Critical illnessBetacoronavirusInternal medicineVirologyInfectious disease (medical specialty)OutbreakDiseaseCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and ThrombosisVenous Thromboembolism Diagnosis and Management